Home › Free Stock Grades › BBNX
Beta Bionics, Inc. (BBNX) Stock Grade
BBNX · Healthcare
A-
Market Cap
$1.2B
P/E Ratio
—
Revenue Growth (YoY)
+53.9%
Net Margin
-73.0%
Return on Equity
—
Dividend Yield
None
About Beta Bionics, Inc.'s fundamentals
Beta Bionics is a healthcare equipment company with a market capitalization of $1.2 billion that is experiencing strong revenue growth of 53.9% year-over-year. However, the company is currently unprofitable, operating at a net margin of -73.0% and reporting a net loss in its latest annual statement. The company does not pay a dividend to shareholders. These metrics suggest Beta Bionics is in an early growth phase, reinvesting heavily into operations while scaling its business.